Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group

• KOIZUMI W

収録刊行物

• Oncology

  Oncology 58 191-197, 2000

詳細情報

• CRID: 1573668925365520256
• NII論文ID: 10021270706
• データソース種別:
  • CiNii Articles